PS
Therapeutic Areas
Oxford Gene Technology Pipeline
| Drug | Indication | Phase |
|---|---|---|
| SureSeq Myeloid MRD Plus NGS Panel | Acute Myeloid Leukemia (MRD detection) | Commercial |
| Companion Diagnostic Development Services | Haematological Malignancies (e.g., Acute Leukaemia) | Development/Commercial |